These agents work in concert to reduce fat deposits. The article reviews the results for patients treated with Lipodissolve and other injection lipolysis treatments. This article describes the author’s experience with lipodissolve, a nonsurgical treatment to reduce fat deposits via the injection of a single component. Download Citation on ResearchGate | Lipodissolve for body sculpting: Article in Journal of Clinical and Aesthetic Dermatology 5(10) · October with.
|Published (Last):||27 August 2011|
|PDF File Size:||10.95 Mb|
|ePub File Size:||8.9 Mb|
|Price:||Free* [*Free Regsitration Required]|
I have encapsulated the long unstructured area before the table of contents into a paragraph. If you feel like to chat unstructured or do not know how to write the four obligatory tildes as signation, please use this paragraph: This site continues to be used innapropriately by Kythera Biopharmaceuticals “Agincourtboy”.
See many comments and attempted edits below by medical professionals. Despite many lipodissolvr by medical professionals some listed belowthis web site offers a very biased view of lipodissolve due to the efforts of a drig company that is trying to damage the lipodissolve industry for their own profit.
Yes – several of the IP addresses including I wish to make some comments and corrections as there is a lot of misinformation flying arficle. First, Lipodissolve is an injection technique. It afticle not the name of a medication as some believe. This notion came about because one Doctor tried to sell the medication “Lipostabil” as Lipodissolve.
Compounding is regulated by each individual State. As for the comment below by N.
Medications such as “Rapamune”, “Infasurf”, “Curosurf” etc. These medications and others containing Phosphatidylcholine are FDA approved. Deoxycholate is also used in a medication amphotercin B deoxycholate. The fact that both Phosphatidylcholine and Deoxycholate are allowed for use in the medications that I list testifies that they are approved for use.
David notes that medications lipodissklve as “fungizone” are no longer available.
lipodisssolve This dose not mean that lipodiszolve ingredients in the medication were articlw, nor does it mean that the ingredients in the medications have been banned, it means usually that the medication is no longer profitable to be commercially used. David also points out that injecting a drug into a fat pad is different than injecting into the blood stream.
I would think that most readers if asked would believe that an injection into the blood stream srticle potentially be much more hazardous as the medication would potentially affect the vital organs. David does note correctly that there is no clinical trail for PCDC. As PCDC is written for as a prescription Drug there was no need to seek FDA approval as both Phosphatidylcholine and Deoxycholate have been approved for use in humans as indicated by their appearance in various medications.
The FDA does not regulate the practice of Medicine, it only regulates the manufacture and safety of medications. The Kansas Board of Healing Arts “is investigating at least a half dozen complaints involving business practices and adverse reactions” I have spoken with chief counsel Mark Stafford about this prior to their decision. The problem in Kansas and elsewhere is that in many cases, there is “non-medical” personnel injecting the public. Poor outcome as noted on many forums is not the fault of the medication, it is because of poor or non-existent training.
Apparently in Kansas, as long as there is a written prescription for a medication, anyone can inject it according to Mr. This is the source of many of the cited problems and is also part of the business practice issue. I mentioned to Mr. Stafford in our conversation that I believe their policy is misleading and potentially dangerous to the public. When someone goes into a Doctors office or Clinic to receive a medical treatment, they assume that the person doing it has adequate training.
I do not think that many folks would allow themselves to be treated if they knew ahead of time that they were going to be treated by the billing clerk. As for the removal of PCDC from use, their decision was not based on any fact aside from these “half dozen complaints” which seem to involve both “business practices” and adverse reactions.
A search of the CDC site does not indicate any reported incidents. There are some common side effects mostly swelling from PCDC all of which can be easily handled by a competent well trained Physician.
There are some reports of severe pain, this is due to too high a concentration of the DC as it requires to be at a higher ph to stay in solution.
Proper training in the technique will usually eliminate this from happening. The banning of PCDC in Brazil was fostered by the fact that people were injecting themselves and their friends. Also, the pharmaceutical industry is not as well controlled as here. In England the issue was that the Drug was not approved. They do not have the same freedom of compounding as we do in the US. Someone asked how PCDC works. Phosphatidylcholine is an emulsifying agent, Deoxycholate is a Bile Salt which has detergent properties.
When injected, they cause fat cell necrosis. This has been shown by a published article by A.
I hope that this helps. This really isn’t helpful, but I think some things that needed to be added to this page is exactly how the drug works to break down fat, any information regarding it’s effectiveness, any studies done on it, possible dangers and the contraversy in the U. As well, I don’t believe that it is currently available in Canada, and if so please site a source, as I can’t find one. It says ‘North America’ to which I think should only be the U. There needs to be sources for that Doctor’s name, and it should be dated and cited as to when it was FDA approved.
The fact it is FDA approved should be readded to the article. I hope this resolves any confusion as to the regulatory status of the drug. Deoxycholate was listed as an inactive component of a no-longer-marketed antifungal agent i.
Furthermore, the approval of deoxycholate as an inactive ingredient in FUNGIZONE was for the intravenous administration of that drug at far lower doses than those administered by medspas.
Because your statements lack the benefit of factual accuracy, I am removing them. Please contact me if you wish to discuss. I agree with nearly all of the facts as you represent them.
But some nuance is needed to understand the current market situation. Implicit in your statements is the appropriateness of “one doctor, one prescription, one patient” as safe, legal, and ethical medical practice. These organizations compound PCDC on a mass scale. This is NOT legal compounding.
While FDA does not regulate medicine, the Agency does regulate drug marketing and manufacturing. Also, if you can provide a reference on the Brazil situation, I would much appreciate it and would be happy to post it. I would say that that while PC and DC are components of approved drugs, they are not the active ingredients. This is very different from saying that they are okay to be used in humans. They are allowed by the FDA as excipients in other drugs – this doesn’t mean that they can be used as active ingredients in drugs without approval.
I just want to make sure that people understand that there is a difference. Our company is the original developers of the protocol which we named Lipodissolve several years ago when no one had ever heard of it. There need to be some clarifications of the growing mis use of our business name where limited knowledge of the statements issued by individuals are made, which cause further confusions to the general public.
Lipodissolve is not a medical term to describe all treatments where phopshatidylcholine is being used. Lipodissolve is not a name or term to describe all treatments where injections are used in cosmetic efforts, ex.
Lipomelt, mesotherapy, Lipo Sculpt and so on. Lipodissolve is not the name of a drug or a product, ex Lipostabil, phosphatidylcholine or others.
We oppose to the repeated and faulty efforts to use our business name in reference to other procedures, licensing problems for sales of products or neglect by clinics that offer procedures while using the Lipodissolve name without the presence of a licensed physician. None of these issues, that are often mixed into the use in part or full of our business name, has anything to do with Lipodissolve but are individual articcle of misuse in some form or the other.
Lipodissolve means only one thing: When these exact protocols are used by a licensed physician that have been lipodissllve and within clinical use we refer to it as ‘Lipodissolve treatment’. We must also remember that there are many kinds of processing being used for phosphatidylcholine manufacturing, and different ‘versions’ of phosphatidylcholine are available on the market based on the raw materials, etc.
Not all of these products that may indicate the same base component are suitable within Lipodissolve protocols, which contain the use of several medications, not only phosphatidylcholine.
This alters the scope of use and ability of lipoxissolve. To refer to this product in sweeping, general terms without a detailed insight into what kind of phosphatidylcholine it refers to, is insufficient.
Licensed physicians who articl worked with us or been affiliated with us, have published studies referring to actual Lipodissolve protocols – not other procedures, other protocols or medications. The safety record is solely a reference to the lipodissolev that is being used in what has been named ‘Lipodissolve’. Unfortunately, infringement on this name has become difficult to regulate and causes other users to pose the name on treatments that have little to do with Lipodissolve.
The MHRA issued a ban on unlicensed import of the medication Lipostabil and the use of unlicensed products. The MHRA require that regional sellers of imported Lipostabil into the UK must be licensed to sell the product and process orders towards patient prescription.
In a recent update to their past decision, MHRA has clarified that their reference is to the licensing and use of the product Lipostabil and not to Lipodissolve. The confusion is created by misinformation often posted by opponents against Lipodissolve based on conflicting views on phosphatidylcholine and mixing up clinical or import violations.
Brazil had no use of Lipodissolve and we have no certified physicians from Brazil on Lipodissolve. Laymen without any medical background or knowledge were using many different medications for experimental cosmetic use, which included tiratricol, aminophyllin, phosphatidylcholine and many, many more. To control this situation Brazil restricted the use of these products.
It has no reflection on Lipodissolve. As we already mentioned Lipodissolve is a name describing a protocol and is not the name of a product. FDA approves medical devices and drugs.
Lipodissolve is the description of a standard protocol use on medical treatments to reduce body fat. It is not the name of a drug, a medical device and cannot be applied for FDA approval, unless it is created into a licensed drug marketed lipoeissolve Lipodissolve.
What would you propose to do? I realize that there is confusion as to the name, but the turth is that Lipodissolve is the most common term used to describe this means to remove fat. I have not heard back from you on what you would like to do.